We support open innovation through industry-academia-government collaboration by leveraging the strengths of Tokyo, where pharmaceutical companies, support organizations, and investors are concentrated.

We aim to establish a cycle of producing start-up companies that dominate the world, and to grow Tokyo and solve social issues through cutting-edge businesses (innovation). For details, please refer to the special site (link to an external site) .